Skip to main content
SpringerLink
Log in

Chronische Wunde

Neue Wege in Forschung und Therapie

Chronic wounds

Novel approaches in research and therapy

  • Leitthema
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Wundheilungsmechanismen können durch unterschiedliche Grunderkrankungen behindert werden und den Zustand einer chronisch schlecht heilenden Wunde entwickeln. Für eine effiziente Therapiestrategie ist es notwendig, die Grunderkrankung zu identifizieren, zu behandeln und die pathologische Wundheilung gezielt zu normalisieren. Hierzu sind detaillierte Kenntnisse über die ablaufenden zellulären und molekularen Mechanismen notwendig. In dieser Übersicht sollen neue Erkenntnisse über die normale und pathologische Wundheilung und die sich daraus ergebenden konservativen Therapieansätze dargestellt werden.

Abstract

Underlying disease may impair normal wound healing, leading to chronic, poorly healing wounds. Efficient treatment strategies require identification and treatment of the underlying disease as well as directed correction of the wound healing defect. A thorough knowledge of tissue repair mechanisms at the cellular and molecular level will help to achieve these goals. This review focuses on new developments in wound healing research and the resulting non-operative therapeutic implications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Armstrong DG, Lavery AL, for the Diabetic Foot Study Consortium (2005) Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 366: 1704–1710

    Article  PubMed  Google Scholar 

  2. Badiavas E, Falanga V (2003) Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 139: 510–516

    Article  PubMed  Google Scholar 

  3. Banda MJ, Knighton DR, Hunt TK, Werb Z (1982) Isolation of a nonmitogenic angiogenesis factor from wound fluid. Proc Natl Acad Sci 79: 7773–7777

    Article  PubMed  CAS  Google Scholar 

  4. Barrick B, Campbell EJ, Owen A (1999) Leukocyte proteinases in wound healing: roles in physiologic and pathologic processes. Wound Rep Reg 7: 410–422

    Article  CAS  Google Scholar 

  5. Bullard KM, Lund L, Mudgett JS et al. (1999) Impaired wound contraction in stromelysin-1-deficient mice. Ann Surg 230: 260–265

    Article  PubMed  CAS  Google Scholar 

  6. Eming SA, Smola H, Krieg T (2002) The treatment of chronic wounds: current concepts and future aspects. Cells Tissues Organs 172: 105–117

    Article  PubMed  CAS  Google Scholar 

  7. Eming SA, Lauer G, Cole M et al. (2004) Increased levels of the soluble variant of the VEGF receptor VEGFR-1 (sFlt-1) are associated with poor prognosis in wound healing. J Invest Dermatol 123: 799–802

    Article  PubMed  CAS  Google Scholar 

  8. Eming SA, Smola-Hess S, Hirche D et al. (2006) A novel property of Povidon-iodine: inhibition of excessive protease levels in chronic non-healing wounds. J Invest Dermatol 126: 2731–2733

    Article  PubMed  CAS  Google Scholar 

  9. Eming SA, Krieg T, Davidson JM (2007) Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 127: 514–525, (Perspective Article)

    Article  PubMed  CAS  Google Scholar 

  10. Eming SA, Krieg T, Davidson JM (2007) Gene therapy and wound healing. Clin Dermatol 25: 79–92

    Article  PubMed  Google Scholar 

  11. Grinnell F, Ho C, Wysocki A (1992) Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting and, cell adhesion assays. J Invest Dermatol 98: 410–416

    Article  PubMed  CAS  Google Scholar 

  12. Grinnell F, Zhu M (1996) Fibronectin degradation in chronic wounds depends on the relative levels of elastase, a1-proteinase inhibitor, and a2-macroglobulin. J Invest Dermatol 106: 335–341

    Article  PubMed  CAS  Google Scholar 

  13. Herouy Y, Hellstern MO, Vanscheidt E et al. (2000) Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers. Lancet 355: 1970–1971

    Article  PubMed  CAS  Google Scholar 

  14. Hubbell JA (2006) Matrix-bound growth factors in tissue repair. Sw Med Wkly 136: 387–391

    CAS  Google Scholar 

  15. auf dem Keller U, Kumin A, Braun S, Werner S (2006) Reactive oxygen species and their detoxification in healing skin wounds. J Invest Dermatol Symp Proc 11: 106–111

    Article  CAS  Google Scholar 

  16. Katz MH, Alvarez AF, Kirsner RS et al. (1991) Human wound fluid from acute wounds stimuates fibroblasts and endothelial cell growth. J Am Acad Dermatol 25: 1054–1058

    Article  PubMed  CAS  Google Scholar 

  17. Kjolseth D, Frank JM, Barker JH et al. (1994) Comparison of the effects of commonly used wound agents on epithelialization and neovascularization. J Am Coll Surg 179: 305–312

    PubMed  CAS  Google Scholar 

  18. Körbling M, Estrov Z (2003) Adult stem cells for tissue repair – a new therapeutic concept. N Engl J Med 349: 570–582

    Article  PubMed  Google Scholar 

  19. Lauer G, Sollberg S, Cole M et al. (2000) Expression and proteolysis of VEGF is increased in chronic wounds. J Invest Dermatol 115: 12–18

    Article  PubMed  CAS  Google Scholar 

  20. Lauer G, Sollberg S, Cole M et al. (2002) Generation of a novel proteolytic resistant VEGF165 variant by a site directed mutation at the plasmin sensitive cleavage site. FEBS Letters 531: 309–313

    Article  PubMed  CAS  Google Scholar 

  21. Loots MA, Lamme EN, Zeegelaar J et al. (1998) Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Deramtol 111: 850–857

    Article  CAS  Google Scholar 

  22. Lutolf MP, Hubbell JA (2005) Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23: 47–55

    Article  PubMed  CAS  Google Scholar 

  23. Martin P (1997) Wound healing – aiming for perfect skin regeneration. Science 276: 75–81

    Article  PubMed  CAS  Google Scholar 

  24. Martin P, Leibovich SJ (2005) Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 15: 599–607

    Article  PubMed  CAS  Google Scholar 

  25. Ono I, Gunji H, Zhang JZ et al. (1995) Studies on cytokines related to wound healing in donor site wound fluid. J Dermatol Sci 10: 241–245

    Article  PubMed  CAS  Google Scholar 

  26. Romer J, Bugge TH, Pyke C et al. (1996) Impaired wound healing in mice with a disrupted plasminogen gene. Nature Med 2: 287–292

    Article  PubMed  CAS  Google Scholar 

  27. Roth D, Piekarek M, Christ H et al. (2006) Plasmin modulates VEGF-A mediated angiogenesis during wound repair. Am J Pathol 168: 670–684

    Article  PubMed  CAS  Google Scholar 

  28. Scharffetter-Kochanek K, Schüller J, Meewes C et al. (2003) Das chronisch venöse Ulcus cruris – Pathogenese und Bedeutung des „aggressiven Mikromilieus“. J Dtsch Dermatol Gesellsch 1: 58–67

    Article  Google Scholar 

  29. Singer AJ, Clark RAF (1999) Cutaneous wound healing. N Engl J Med 341: 738–746

    Article  PubMed  CAS  Google Scholar 

  30. Streit M, Beleznay Z, Braathen LR (2006) Topical application of the TNF-a antibody Infliximab improves healing in chronic wounds. Int Wound J 3: 171–179

    Article  PubMed  Google Scholar 

  31. Vogt PM, Hauser J, Rossbach O et al. (2001) Polyvinyl pyrrolidone-iodine liposome hydrogel improves epithelialization by combining moisture and antisepis. A new concept in wound therapy. Wound Repair Regen 9: 116–122

    Article  PubMed  CAS  Google Scholar 

  32. Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83: 835–870

    PubMed  CAS  Google Scholar 

  33. Wlaschek M, Scharffetter-Kochanek K (2005) Oxidative stress in chronic venous leg ulcers. Wound Rep Reg 13: 452–461

    Article  Google Scholar 

  34. Wozniak G (2000) Vom Ulcus cruris zum Myokardinfarkt. Med Welt 51: 25–30

    Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin: S.A. Eming. T. Krieg Beratertätigkeit bei Bayer Innovation GmbH.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie und Venerologie, Universität zu Köln, Joseph-Stelzmann Straße 9, 50931, Köln, Deutschland

    S.A. Eming, J. Kaufmann, R. Löhrer & T. Krieg

Authors
  1. S.A. Eming
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Kaufmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Löhrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Krieg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S.A. Eming.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eming, S., Kaufmann, J., Löhrer, R. et al. Chronische Wunde. Hautarzt 58, 939–944 (2007). https://doi.org/10.1007/s00105-007-1402-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-007-1402-1

Schlüsselwörter

Keywords

Search

Navigation